PolyNovo (ASX: PNV) has acquired Taiwanese Food and Drug Administration (FDA) approval for the company’s dermal scaffolding product. The company said it has also made a contract with Evermed, a Taiwan-based distributor to sell BTM. PolyNovo Managing Director Paul Brennan commented that the approval is an exciting development for PolyNovo.
King River Resources Commences Drilling at Mt Remarkable Gold Project, Stock Up ~7%
The stock of Australian explorer King River Resources Limited (ASX: KRR) traded higher by 6.896 percent to $0.031 on 28 October 2020 (AEST 1:37 PM). The Company aiming towards testing for high-grade gold mineralization has commenced a 2,500m RC drill program at Western Australia-based Mt Remarkable Project.
* CLINUVEL’s (CUV) Afamelanotide To Be Used In Acute Stroke Patients
ASX 200 listed company CLINUVEL PHARMACEUTICALS LIMITED’s (ASX: CUV) drug afamelanotide shall be used in patients suffering from acute stroke. The study will assess the safety as well as the efficacy of afamelanotide in arterial ischaemic stroke (AIS).